Cat.#: ACPP-1334
| Despition | DRP1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1018 | Recombinant Human APLP2 Protein (6×His Tag) (AC1018) | 50 µg | inquiry |
| ACPP-1391 | Human Apo D Protein (AC1391) | 2 µg | inquiry |
| ACPP-1357 | P2Y12 Blocking Peptide (AC1357) | 250 µg | inquiry |
| ACPP-1151 | Recombinant HuD Protein (AC1151) | 10 µg | inquiry |
| ACPP-1437 | Human LINGO1 Protein (AC1437) | 5 µg | inquiry |
| ACPP-1461 | Human Luteinizing Hormone Protein (AC1461) | 100 µg | inquiry |
| ACPP-1775 | Human SNPH Protein (AC1775) | 10 µg | inquiry |
| ACPP-1731 | Human DNAJC19 Protein (AC1731) | 2 µg | inquiry |
| ACPP-1838 | Human APO D Protein, GST (AC1838) | 2 µg | inquiry |
| ACPP-1404 | Human p59-Fyn Protein (AC1404) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.